Intra Cellular Ownership
| ITCIDelisted Stock | USD 131.87 0.03 0.02% |
Intra |
Intra Stock Ownership Analysis
About 96.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.73. Intra Cellular Therapies had not issued any dividends in recent years. Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. Intra-Cellular Ther operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 512 people. To learn more about Intra Cellular Therapies call Sharon Mates at 646 440 9333 or check out https://www.intracellulartherapies.com.Intra Cellular Therapies Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Intra Cellular insiders, such as employees or executives, is commonly permitted as long as it does not rely on Intra Cellular's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Intra Cellular insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Intra Cellular Outstanding Bonds
Intra Cellular issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Intra Cellular Therapies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Intra bonds can be classified according to their maturity, which is the date when Intra Cellular Therapies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Intesa Sanpaolo 571 Corp BondUS46115HAW79 | View | |
| ISPIM 77 Corp BondUS46115HAU14 | View | |
| ISPIM 3875 12 JAN 28 Corp BondUS46115HBD89 | View | |
| ISPIM 4375 12 JAN 48 Corp BondUS46115HBE62 | View | |
| ISPIM 3875 14 JUL 27 Corp BondUS46115HBB24 | View | |
| US46115HBQ92 Corp BondUS46115HBQ92 | View | |
| ISPIM 47 23 SEP 49 Corp BondUS46115HBN61 | View | |
| ISPIM 4 23 SEP 29 Corp BondUS46115HBL06 | View |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in national income and product accounts. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Intra Stock
If you are still planning to invest in Intra Cellular Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intra Cellular's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |